001     908202
005     20220621190117.0
024 7 _ |a 10.1109/NSSMIC.2017.8532870
|2 doi
037 _ _ |a FZJ-2022-02453
100 1 _ |a Kops, E. Rota
|0 P:(DE-HGF)0
|b 0
111 2 _ |a 2017 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC)
|c Atlanta
|d 2017-10-21 - 2017-10-28
|w GA
245 _ _ |a Attenuation Correction of Cerebellum in PET/MR Data
260 _ _ |c 2017
336 7 _ |a Abstract
|b abstract
|m abstract
|0 PUB:(DE-HGF)1
|s 1655806508_15481
|2 PUB:(DE-HGF)
336 7 _ |a Conference Paper
|0 33
|2 EndNote
336 7 _ |a INPROCEEDINGS
|2 BibTeX
336 7 _ |a conferenceObject
|2 DRIVER
336 7 _ |a Output Types/Conference Abstract
|2 DataCite
336 7 _ |a OTHER
|2 ORCID
520 _ _ |a Abstract:Most approaches of modelling neuroreceptor PET studies apply the cerebellum as reference area. Therefore, it is mandatory that the respective attenuation correction (AC) method for reconstructing the emission data is most appropriate regarding cerebellar areas. PET data from PET/MR scanners require alternative AC methods. These ought to be tested with respect to the performance within the cerebellum. This study aimed to compare various AC methods for PET/MR data focussing on the cerebellum. Data of 16 subjects undergoing 18 FDG imaging in the Siemens 3TMR-BrainPET scanner and a whole head CT scan at the same day were used. The latter were transformed to CT-based attenuation maps (AM CT ). The MR images were used to obtain AMs using the Boston-MGH method (AM MGH ), the London-UCL method (AM UCL ), the CT-template-based (AM CT-Juel ) and Tx-template-based (AM Tx-Juel ) Juelich methods. BrainPET emission data were reconstructed with the five AM s . Using the SUIT tool the cerebellum was extracted from the MR images and normalized to a cerebellum VOI atlas. The cerebellum of the PET data was extracted by applying the same parameters. Correlation plots with regression equations, coefficients of determination R 2 , normalized and absolute normalized errors (NErr) between AM CT and the other four AM s were calculated. The values of cerebellar NErr varied to a high extent between the four AC methods. In one subject AM MGH showed the lowest NErr (3.03±1.60%), in three participants the AMUCL performed best (NErr from -0.13±2.33% to 0.91±2.93%), in three others the AM Tx-Juel had the best results (NErr from -1.24±3.01% to 0.86±2.07%), while for the remaining seven subjects the AM CT-Juel performed best (NErr from -2.08±0.94% to 7.98±3.43%). Our results demonstrate that the quantitation of radiotracer uptake in the cerebellum is very susceptible to the respective attenuation correction applied to the PET data. This, in turn, has to be considered in neuroreceptor modelling studies which rely on the cerebellum as reference.
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef Conference
700 1 _ |a Hautzel, H.
|0 P:(DE-Juel1)132313
|b 1
700 1 _ |a Herzog, H.
|0 P:(DE-Juel1)131768
|b 2
|u fzj
700 1 _ |a Lerche, C.
|0 P:(DE-Juel1)164254
|b 3
|u fzj
700 1 _ |a Shah, N. J.
|0 P:(DE-Juel1)131794
|b 4
|u fzj
773 _ _ |a 10.1109/NSSMIC.2017.8532870
909 C O |o oai:juser.fz-juelich.de:908202
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)131768
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)164254
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)131794
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 0
920 1 _ |0 I:(DE-Juel1)INM-4-20090406
|k INM-4
|l Physik der Medizinischen Bildgebung
|x 0
920 1 _ |0 I:(DE-Juel1)INM-11-20170113
|k INM-11
|l Jara-Institut Quantum Information
|x 1
920 1 _ |0 I:(DE-Juel1)VDB1046
|k JARA-BRAIN
|l Jülich-Aachen Research Alliance - Translational Brain Medicine
|x 2
980 _ _ |a abstract
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-4-20090406
980 _ _ |a I:(DE-Juel1)INM-11-20170113
980 _ _ |a I:(DE-Juel1)VDB1046
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21